News Concordia and Actavis face UK pricing probe Firms colluded to hike prices, says competition watchdog.
News Lords defy government with post-Brexit guarantee for EU nati... Peers introduce amendment to Brexit bill.
News Biotech leaders unite against Trump travel ban Spokesman also causes confusion over pricing policy.
News Brexit could delay drug launches, former MHRA chief warns Britain will be in "second or third tier" of drug launches, experts warn.
News Pharma CEOs under scrutiny after Trump meeting Pharma leaders grilled by analysts after Trump meeting.
News Pharma CEOs to meet Trump today Pharma CEOs including Novartis’ Joe Jimenez are to meet Donald Trump this afternoon – following a turbulent start to his presidency and his attacks on the industry over pricing.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
